Are You Not Interchanged? FDA's Recent Biosimilar Labeling Guidance Chips Away at Interchangeable Product Advantages. | Foley Hoag LLP

Interchangeable biosimilar products would not be allowed to disclose or explain their interchangeability designations in their products’ labels under FDA’s new draft guidance. ...

Related Keywords

,Foley Hoag ,Additional Draftq As On Biosimilar Development ,Drug Administration ,Draft Guidance ,Interchangeable Biosimilar Products ,Biosimilar Development ,Prescribing Information ,Purple Book Database ,Licensed Biological Products ,Purple Book ,Biologics Price Competition ,Innovation Act ,Appropriations Act ,